Guillain-Barre Syndrome Treatments

Aetna covers IVIG (HCPCS 90283), therapeutic plasmapheresis (CPT 36514), and outpatient pulmonary rehabilitation for Guillain‑Barré syndrome only when the specific medical‑necessity/selection criteria in CPB 0206 (IVIG), CPB 0285 (plasmapheresis) and CPB 0032 (pulmonary rehab) are met. Therapies considered experimental/investigational and not covered for GBS include corticosteroids (not recommended), alemtuzumab, eculizumab, rituximab, interferons, acupuncture, neuromuscular electrical stimulation and numerous listed J‑codes/agents.

"Outpatient pulmonary rehabilitation program for patients with Guillain-Barre syndrome when criteria listed in CPB 0032 - Pulmonary Rehabilitation are met."

Sign up to see full coverage criteria, indications, and limitations.